Content
01/10/2025 Basel Switzerland
Rhygaze completed $86 million Series A Round funding. Investors include Google Ventures (lead), ARCH Venture Partners, F-Prime Capital, Novartis Venture Fund, BioGeneration Ventures.
#Biotech  #Life Science  
About
RhyGaze AG is pioneering a transformative approach with cone optogenetics, which has the potential to revolutionize vision restoration for patients suffering from blindness.
Startup
Rhygaze
https://rhygaze.com Claim Profile
Location:
Basel Switzerland
Sector:
Biotech
Life Science
Download StockFan App Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.